TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 (original) (raw)

• Pflanz, S. et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16, 779–790 (2002).
  Article CAS Google Scholar
• Hunter, C.A. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5, 521–531 (2005).
  Article CAS Google Scholar
• Trinchieri, G., Pflanz, S. & Kastelein, R.A. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19, 641–644 (2003).
  Article CAS Google Scholar
• Trinchieri, G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3, 133–146 (2003).
  Article CAS Google Scholar
• Cua, D.J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744–748 (2003).
  Article CAS Google Scholar
• Yen, D. et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116, 1310–1316 (2006).
  Article CAS Google Scholar
• Cua, D.J. & Kastelein, R.A. TGF-β, a 'double agent' in the immune pathology war. Nat. Immunol. 7, 557–559 (2006).
  Article CAS Google Scholar
• Weaver, C.T., Harrington, L.E., Mangan, P.R., Gavrieli, M. & Murphy, K.M. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677–688 (2006).
  Article CAS Google Scholar
• Nussenblatt, R.B. Bench to bedside: new approaches to the immunotherapy of uveitic disease. Int. Rev. Immunol. 21, 273–289 (2002).
  Article Google Scholar
• Jabs, D.A. et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am. J. Ophthalmol. 130, 492–513 (2000).
  Article CAS Google Scholar
• Nussenblatt, R.B. et al. Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial. Proc. Natl. Acad. Sci. USA 22, 7462–7466 (1999).
  Article Google Scholar
• Becker, M.D., Garman, K., Whitcup, S.M., Planck, S.R. & Rosenbaum, J.T. Inhibition of leukocyte sticking and infiltration, but not rolling, by antibodies to ICAM-1 and LFA-1 in murine endotoxin-induced uveitis. Invest. Ophthalmol. Vis. Sci. 42, 2563–2566 (2001).
  CAS PubMed Google Scholar
• Nussenblatt, R.B. Proctor lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications. Invest. Ophthalmol. Vis. Sci. 32, 3131–3141 (1991).
  CAS PubMed Google Scholar
• Crane, I.J. et al. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis. J. Leukoc. Biol. 79, 435–443 (2006).
  Article CAS Google Scholar
• Tarrant, T.K., Silver, P.B., Chan, C.C., Wiggert, B. & Caspi, R.R. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis. J. Immunol. 161, 122–127 (1998).
  CAS PubMed Google Scholar
• Tarrant, T.K. et al. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J. Exp. Med. 189, 219–230 (1999).
  Article CAS Google Scholar
• Caspi, R.R. et al. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response. J. Immunol. 157, 2668–2675 (1996).
  CAS PubMed Google Scholar
• Cho, M.L. et al. STAT3 and NF-κB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J. Immunol. 176, 5652–5661 (2006).
  Article CAS Google Scholar
• Komiyama, Y. et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177, 566–573 (2006).
  Article CAS Google Scholar
• Nakae, S., Nambu, A., Sudo, K. & Iwakura, Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171, 6173–6177 (2003).
  Article CAS Google Scholar
• Nakae, S. et al. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 100, 5986–5990 (2003).
  Article CAS Google Scholar
• Yu, C.R. et al. Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling. J. Immunol. 173, 737–746 (2004).
  Article CAS Google Scholar
• Egwuagu, C.E. et al. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J. Immunol. 168, 3181–3187 (2002).
  Article CAS Google Scholar
• Stumhofer, J.S. et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7, 937–945 (2006).
  Article CAS Google Scholar
• Takase, H. et al. Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): potential neuroprotective role of SOCS proteins. J. Neuroimmunol. 168, 118–127 (2005).
  Article CAS Google Scholar
• Caspi, R.R. et al. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J. Immunol. 140, 1490–1495 (1988).
  CAS PubMed Google Scholar
• Weaver, C.T., Hatton, R.D., Mangan, P.R. & Harrington, L.E. IL-17 Family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25, 821–852 (2007).
  Article CAS Google Scholar
• Owaki, T. et al. A role for IL-27 in early regulation of Th1 differentiation. J. Immunol. 175, 2191–2200 (2005).
  Article CAS Google Scholar
• Villarino, A.V. et al. IL-27 limits IL-2 production during Th1 differentiation. J. Immunol. 176, 237–247 (2006).
  Article CAS Google Scholar
• Batten, M. et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7, 929–936 (2006).
  Article CAS Google Scholar
• Yoshimura, T. et al. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J. Immunol. 177, 5377–5385 (2006).
  Article CAS Google Scholar
• Jovanovic, D.V. et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-β and TNF-α, by human macrophages. J. Immunol. 160, 3513–3521 (1998).
  CAS PubMed Google Scholar
• Watford, W.T. et al. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 202, 139–156 (2004).
  Article CAS Google Scholar
• Villarino, A.V. & Hunter, C.A. Biology of recently discovered cytokines: discerning the pro- and anti-inflammatory properties of interleukin-27. Arthritis Res. Ther. 6, 225–233 (2004).
  Article CAS Google Scholar
• Chen, Z. et al. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. USA 103, 8137–8142 (2006).
  Article CAS Google Scholar
• Tato, C.M., Laurence, A. & O'Shea, J.J. Helper T cell differentiation enters a new era: le roi est mort; vive le roi!. J. Exp. Med. 203, 809–812 (2006).
  Article CAS Google Scholar
• Li, J., Gran, B., Zhang, G.X., Rostami, A. & Kamoun, M. IL-27 subunits and its receptor (WSX-1) mRNAs are markedly up-regulated in inflammatory cells in the CNS during experimental autoimmune encephalomyelitis. J. Neurol. Sci. 232, 3–9 (2005).
  Article CAS Google Scholar
• Sonobe, Y. et al. Production of IL-27 and other IL-12 family cytokines by microglia and their subpopulations. Brain Res. 1040, 202–207 (2005).
  Article CAS Google Scholar
• Hamzaoui, K. et al. Cytokine profile in Behcet's disease patients. Relationship with disease activity. Scand. J. Rheumatol. 31, 205–210 (2002).
  Article Google Scholar
• Saruhan-Direskeneli, G., Yentur, S.P., Akman-Demir, G., Isik, N. & Serdaroglu, P. Cytokines and chemokines in neuro-Behcet's disease compared to multiple sclerosis and other neurological diseases. J. Neuroimmunol. 145, 127–134 (2003).
  Article CAS Google Scholar
• Okhravi, N., Odufuwa, B., McCluskey, P. & Lightman, S. Scleritis. Surv. Ophthalmol. 50, 351–363 (2005).
  Article Google Scholar
• Deuter, C.M., Kotter, I., Gunaydin, I., Zierhut, M. & Stubiger, N. Ocular involvement in Behcet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a. Ophthalmologe 101, 129–134 (2004).
  Article CAS Google Scholar
• Calguneri, M. et al. Effects of interferon alpha treatment on the clinical course of refractory Behcet's disease: an open study. Ann. Rheum. Dis. 62, 492–493 (2003).
  Article CAS Google Scholar
• Nussenblatt, R.B. et al. Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration. J. Autoimmun. 21, 283–293 (2003).
  Article CAS Google Scholar
• Egwuagu, C.E., Yu, C.R., Li, Z. & Nussenblatt, R.B. SOCS5 mRNA levels in peripheral blood mononuclear cells (PBMC): a potential bio-marker for monitoring response of uveitis patients to Daclizumab therapy. J. Autoimmun. 24, 39–46 (2005).
  Article CAS Google Scholar
• Hofmann, H., Schulz-key, S., Hertle, D. & Kirsch, M. Orgaotypic cultures of the rat retina. in New Methods for Culturing Cells from Nervous Tissues—Bio Valley Monogr. Vol. 1 (eds. Poindron, P., Piguet, P. & Forster, E.) 58–73 (Karger, Basel, Switzerland, 2005).
  Chapter Google Scholar